Nevanac

Nevanac

nepafenac

Manufacturer:

Novartis

Distributor:

Zuellig
/
Firma Chun Cheong
Concise Prescribing Info
Contents
Nepafenac
Indications/Uses
Treatment of pain & inflammation associated w/ cataract surgery.
Dosage/Direction for Use
1 drop tds beginning 1 day prior to surgery, continued on the day of surgery up to the 1st 2 wk post-op.
Contraindications
Hypersensitivity to nepafenac or to other NSAID.
Special Precautions
Risk of increased bleeding time due to interference w/ thrombocyte aggregation. Increased ocular tissue bleeding (eg, hyphemas) in conjunction w/ ocular surgery. Increased potential for healing problems w/ concomitant use of topical steroids. Monitor corneal condition. Discontinue use in patients w/ corneal epithelial breakdown. Avoid wearing contact lenses during administration. Pregnancy & lactation. Childn <10 yr.
Adverse Reactions
Capsular opacity, decreased visual acuity, foreign body sensation, increased IOP, sticky sensation.
MIMS Class
Ophthalmic Decongestants, Anesthetics, Anti-Inflammatories
ATC Classification
S01BC10 - nepafenac ; Belongs to the class of non-steroidal antiinflammatory agents. Used in the treatment of inflammation of the eye.
Presentation/Packing
Form
Nevanac ophthalmic susp 0.1 % w/v
Packing/Price
(bottle) 5 mL x 1's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in